


China Regenerative Medicine International
Biotechnology Research • 108 Gloucester Road, Wanchai, Hong Kong • 11-20 Employees
Company overview
| Headquarters | 108 Gloucester Road, Wanchai, Hong Kong |
| Phone number | +85239668388 |
| Website | |
| SIC | 873 |
| Keywords | Biotechnology, CRO, Medical Device, Cell Therapy, Stem Cell, Cell Processing |
| Founded | 2001 |
| Employees | 11-20 |
| Socials |
Key Contacts at China Regenerative Medicine International
Carmen Cheung
Director Of Hr And Admin
Anthony Chan
Chief Technology Officer
Lv Rebecca
Hr & Admin Director
Carmen Chim
Business Director
China Regenerative Medicine International Email Formats
China Regenerative Medicine International uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About China Regenerative Medicine International
China Regenerative Medicine International Limited ("CRMI") is principally engaged in R&D, production and distribution of bio-medical and healthcare products, consists of : 1) Cellular Therapy China Stem Cell Clinical Application Centre is currently built in Hong Kong, which complies with the highest standards set forth by EMA, US FDA and CFDA, set to be the world's leading GMP centre specializing in stem cell clinical applications and gene therapy, and a regional supply centre of cellular products for research, development and clinical purposes. Smaller scale but similar graded GMP cell processing facilities are operating in Suzhou, and will be serving in Tianjin, Shenzhen and others in the future. Inside those, we also provide adult tissue storage service for unmet medical needs. 2) Tissue Engineering Bio-Medical Devices We own three manufacturing plants in Xian and Shenzhen and successfully develop and launch : a) the world's unique acellular corneal stroma (Acornea) for laminar keratoplasty that can help corneal blindness patient restoring their vision b) tissue engineering skin (ActivSkin) which contain human live cell for burn skin and ulcer recovery c) Calcined Bovine Bone (CBB) which is bone generative powder for dental implantation and to treat periodontal defects d) Acellular Small Intestinal Submucosa (Resunin), which is for the repair of soft tissue in fistula to maintains the function of the anal sphincter e) Autologous Chondrocyte Implantation - Cell Sheet, which is the fourth generation technique to grow knee cartilage into cell sheet for reconstruction of knee function without prosthesis application. 3) Cosmetics & Healthcare Products Utilizing cell growth factors derived from TE process to develop avant-grade cosmetics & skincare products 4) Medical Equipment & Other Services 3D perfusion cell culture technology used in pre-clinical drug efficacy and toxicity testing and 3D perfusion bioreactors were developed and launched
China Regenerative Medicine International revenue & valuation
| Annual revenue | $37,500,000 |
| Revenue per employee | $2,344,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $120,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
China Regenerative Medicine International has 8 employees across 5 departments.
Departments
Number of employees
Funding Data
China Regenerative Medicine International has never raised funding before.
China Regenerative Medicine International Tech Stack
Discover the technologies and tools that power China Regenerative Medicine International's digital infrastructure, from frameworks to analytics platforms.
Web server extensions
Web servers
SSL/TLS certificate authorities
Operating systems
Frequently asked questions
4.8
40,000 users



